On Tuesday, Shares of Constellium NV (NYSE:CSTM), lost -1.48% to $8.66.
Constellium N. V., declared that Ms. Martha Brooks has been designated as a Special Advisor to the Board of Directors. The Board anticipates to put forward the nomination of Ms. Brooks as a Non-Executive Director at the Company’s Annual General meeting to be held in June 2016.
The Company also declared the resignation of Mathew Nord from the Constellium Board. “I warmly thank Matt Nord for his continuous support over the years. As a partner with Apollo, Matt has played an important role in Constellium’s transformation since 2011,” stated Pierre Vareille, Chief Executive Officer of Constellium. “I welcome Martha Brooks whose long track record in and extensive knowledge of the aluminium industry will be a key asset in Constellium’s future development,” he added.
Ms. Martha Finn Brooks was until her retirement in May 2009, President and Chief Operating Officer of Novelis, Inc, where she held senior positions from 2005. From 2002 to 2005, she served as Corporate Senior Vice President and President and Chief Executive Officer of Alcan Rolled Products, Americas and Asia. She is presently a member of the Boards of Directors of Bombardier Inc. and Jabil Circuit Inc. and has formerly served as a director of Harley Davidson and International Paper.
Constellium N.V. engages in the design, manufacture, and sale of specialty rolled and extruded aluminum products for the aerospace, packaging, and automotive end-markets. The company operates in three segments: Aerospace & Transportation, Packaging & Automotive Rolled Products, and Automotive Structures & Industry.
Shares of WPCS International Incorporated (NASDAQ:WPCS), inclined 7.88% to $1.78, during its last trading session.
WPCS International Incorporated, declared that it secured nearly $1.9 million in new contracts in the month of November, 2015 as contrast to $1.1 million during the same period last year.
According to Sebastian Giordano, Interim CEO of WPCS, “This is a testament to our Suisun Operations leadership. Just thirty days ago, we implemented an expansion of our Suisun administration team, now under the supervision of Butch Roller and the day-to-day administration of Rick Ruth. They responded, in what was clearly a transitional month, by generating a 72.7% improvement in contracts signed as contrast to November 2014.”
WPCS International Incorporated provides low voltage communication infrastructure services in the public services, healthcare, energy, and corporate enterprise markets worldwide.
Finally, Shares of iKang Healthcare Group Inc (ADR) (NASDAQ:KANG), ended its last trade with -0.77% loss, and closed at $19.35.
iKang Healthcare Group, the largest provider in China’s fast growing private preventive healthcare services market with a market share of 13.6% in terms of revenue in calendar year 2014, declared its unaudited financial results for the fiscal second quarter ended September 30, 2015.
Fiscal Second Quarter ended September 30, 2015 Financial Highlights
- Net revenues were US$98.6 million, an improvement of 23.9% year-over-year
- Gross profit was US$45.5 million, an improvement of 8.6% year-over-year
- Operating income was US$16.0 million, a decline of 24.1% year-over-year
- Non-GAAP operating income was US$16.5 million, a decline of 24.2% year-over-year
- Non-GAAP EBITDA was US$24.1 million, a decline of 9.8% year-over-year
- Net income attributable to the Company was US$11.6 million, a decline of 24.9% year-over-year
- Non-GAAP net income attributable to the Company was US$12.1 million, a decline of 24.9% year-over-year
- Basic and diluted income per ADS attributable to common shareholders were US$0.17 and US$0.17, respectively, as contrast to US$0.24 and US$0.23, respectively, in the fiscal second quarter of 2014
- Non-GAAP basic and diluted income per ADS attributable to common shareholders were US$0.18 and US$0.17, respectively, as contrast to US$0.25 and US$0.24, respectively, in the fiscal second quarter of 2014
iKang Healthcare Group, Inc., together with its auxiliaries, provides preventive healthcare solutions in the People’s Republic of China. It operates in two segments, Medical Examinations and Other Medical Services, and Dental Services.